Literature DB >> 17451140

Hypertension and the kidney.

J M Krzesinski1, E P Cohen.   

Abstract

The kidney could be the cause of essential hypertension which can also cause renal disease. High blood pressure is also very common in chronic kidney disease, and is moreover a well-known risk factor for a faster progression of kidney failure. Hypertension and kidneys are thus closely linked. Hypertension must be aggressively treated in patients suffering from chronic kidney disease, with a blood pressure goal of less than 130/80 mmHg, even lower than 125/75 mmHg when proteinuria is over 1g/day, using optimal and effective antihypertensive drugs. Among them, the blockers of the renin-angiotensin axis offer nephroprotective but also cardioprotective properties beyond their effect on blood pressure.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17451140     DOI: 10.1179/acb.2007.002

Source DB:  PubMed          Journal:  Acta Clin Belg        ISSN: 1784-3286            Impact factor:   1.264


  5 in total

1.  Rosuvastatin beneficially alters the glomerular structure of kidneys from spontaneously hypertensive rats (SHRs).

Authors:  Erica Peres de Barros; Angélica Beatriz Garcia-Pinto; Priscilla Yório Machado; Mário José dos Santos Pereira; Jorge José de Carvalho
Journal:  J Mol Histol       Date:  2011-06-14       Impact factor: 2.611

2.  Low-Intensity physical activity beneficially alters the ultrastructural renal morphology of spontaneously hypertensive rats.

Authors:  Angélica Beatriz Garcia-Pinto; Verônica Soares de Matos; Vinicius Rocha; Jéssica Moraes-Teixeira; Jorge José Carvalho
Journal:  Clinics (Sao Paulo)       Date:  2011       Impact factor: 2.365

3.  Anti-Renal Fibrotic Effect of Exercise Training in Hypertension.

Authors:  Ching Huang; Yi-Yuan Lin; Ai-Lun Yang; Tang-Wei Kuo; Chia-Hua Kuo; Shin-Da Lee
Journal:  Int J Mol Sci       Date:  2018-02-20       Impact factor: 5.923

4.  LC-MS analysis of Myrica rubra extract and its hypotensive effects via the inhibition of GLUT 1 and activation of the NO/Akt/eNOS signaling pathway.

Authors:  Jing Li; Huiling Wang; Jian Li; Yonggang Liu; Hong Ding
Journal:  RSC Adv       Date:  2020-02-04       Impact factor: 4.036

Review 5.  Hypertensive encephalopathy.

Authors:  Mostafa Sharifian
Journal:  Iran J Child Neurol       Date:  2012
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.